Universal Biosensors Inc (UBI.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 162 | 163 | 162 | 165 | 223 |
| Accounts receivable | 210 | 23 | 704 | -266 | 942 |
| Other Working Capital | 4,319 | 16 | -244 | 21 | 4,420 |
| Other Operating Activity | -6,819 | -3,922 | -4,379 | -3,290 | -5,018 |
| Operating Cash Flow | $-2,128 | $-3,719 | $-3,757 | $-3,369 | $567 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -31 | -46 | -255 | -34 |
| Investing Cash Flow | $-8 | $-31 | $-46 | $-255 | $-34 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -254 | -238 | N/A | -310 | -304 |
| Common Stock Issued | 0 | 0 | 0 | -394 | 9,909 |
| Other Financing Activity | 0 | 0 | 0 | 4 | -475 |
| Financing Cash Flow | $-254 | $-238 | $0 | $-700 | $9,130 |
| Exchange Rate Effect | 27 | 5 | -3 | -2 | -26 |
| Beginning Cash Position | 4,916 | 8,899 | 12,705 | 17,031 | 7,394 |
| End Cash Position | 2,553 | 4,916 | 8,899 | 12,705 | 17,031 |
| Net Cash Flow | $-2,390 | $-3,987 | $-3,803 | $-4,324 | $9,663 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,128 | -3,719 | -3,757 | -3,369 | 567 |
| Capital Expenditure | -8 | -31 | -46 | -255 | -34 |
| Free Cash Flow | -2,136 | -3,750 | -3,803 | -3,624 | 533 |